Therapy Targets SARS-CoV-2 Infection-Induced Cell Death

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19.

Cite

CITATION STYLE

APA

Zhu, Z., Shi, J., Li, L., Wang, J., Zhao, Y., & Ma, H. (2022, May 17). Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2022.870216

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free